SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-077943
Filing Date
2021-03-11
Accepted
2021-03-11 17:06:28
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d142745ds3.htm S-3 308702
2 EX-1.2 d142745dex12.htm EX-1.2 208882
3 EX-5.1 d142745dex51.htm EX-5.1 18417
4 EX-5.2 d142745dex52.htm EX-5.2 7752
5 EX-23.1 d142745dex231.htm EX-23.1 2192
6 GRAPHIC g142745ex51.jpg GRAPHIC 2484
7 GRAPHIC g142745ex52.jpg GRAPHIC 2886
8 GRAPHIC g142745g24k99.jpg GRAPHIC 53325
  Complete submission text file 0001193125-21-077943.txt   623816
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254175 | Film No.: 21734121
SIC: 2834 Pharmaceutical Preparations